Global Ambulatory Arrhythmia Monitoring Devices Market to Grow at a CAGR of 6.8% in the Forecast Period 2024-2032, Driven by the Increased Focus on Early Disease Detection and Prevention

A significant portion of the populations of USA and Europe suffers from some kind of cardiovascular disease, and this number is expected to rise in future. Cardiac monitoring devices may enable positive health outcomes through early and accurate detection of symptoms, thereby reducing mortality and need for hospitalization. The use of such wearable or implantable devices is increasing as people seek better and efficient diagnostic solutions.

Ambulatory arrhythmia monitoring devices are used to detect and diagnose randomly occurring cardiac arrhythmia. Arrhythmia symptoms usually appear suddenly and last for a short time. As a result, by the time the person suffering symptoms sees a doctor, the symptoms may have faded, making arrhythmia diagnosis harder. Ambulatory monitoring equipment are preferred in these situations. These devices have the ability to monitor heart activity for longer periods of time, enhancing the odds of detecting arrhythmia during the assessment period.

Leading companies are looking to expand their capacities to offer increasingly sophisticated and efficient products that monitor cardiac rhythm. For example, in 2021, Philips announced that the company had agreed to acquire Paris-based Cardiologs, whose FDA-cleared electrocardiogram analysis platform used artificial intelligence (AI) to enable the diagnosis of atrial fibrillation and other heart rhythm disorders. Similarly, Hillrom announced that it would buy Seattle-based start-up Bardy Diagnostics in 2021. Bardy Diagnostics, founded in 2013, produced an electrocardiogram (ECG) patch that could be worn for up to two weeks to help detect arrhythmias.

Technological advances have enabled novel wearable devices that present new ways to diagnose and manage cardiovascular diseases and associated risk factors. With time, such devices have become more sophisticated, their capacity to diagnose cardiovascular diseases and risk factors enhanced, and ease of use increased. USA is a major market in the direct-to-consumer healthcare sector. While the number of people living with heart disease has risen in USA and Europe, such increase may be associated with progress made in diagnostic and monitoring capabilities. Thus, an ageing global population, growing focus on prevention and early disease-detection, advancements in technology, and desire for improved quality of life are expected to be major drivers of the global ambulatory arrhythmia monitoring devices market.  Also, cardiac arrhythmia is common among COVID-19 patients. In light of the risk of arrhythmias to people suffering from COVID-19, it is expected that the demand for cardiac monitoring devices would increase.

Presently, several devices are employed to assess cardiac rhythm anomalies in ambulatory patients. These include Patient-and-Event-Activated Intermittent Recorders; External Loop Recorders, Pre-symptom Memory Loop Cardiac Event Recorders; Auto-trigger External Loop Recorders; Implantable or Insertable Loop Recorders, Pre-symptom Memory Loop Cardiac Event Recorders; Post-symptom Event Recorders; Continuous Realtime Attended Remote Cardiac Monitors; Mobile Cardiac Outpatient Telemetry System (CardioNet); and Remote Event Monitor (REM). Developments in continuous real-time remote cardiac monitoring have led to better diagnosis.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Findings of the Report:

• The global ambulatory arrhythmia monitoring devices market is likely to be driven by an ageing global population, growing focus on early disease detection and prevention, desire for improved quality of life, and technologically advanced devices.

• Demand for ambulatory arrhythmia monitoring devices may also see an increase due to the spread of COVID-19.

• Major firms are looking to expand their capabilities to provide increasingly sophisticated and efficient products monitoring cardiac rhythm.

Global Ambulatory Arrhythmia Monitoring Devices Market Segmentation

By device type, the global ambulatory arrhythmia monitoring devices market is segmented into:

• Resting ECG
• Event Monitor
• Implantable Cardiac Monitor
• Holter Monitor
• Mobile Cardiac Telemetry Devices
• Others

By end-user, the global ambulatory arrhythmia monitoring devices market is classified according to:

• Hospitals and Clinics
• Diagnostic Centres 
• Ambulatory Surgical Centres    
• Homecare Settings
• Others

By region, the global ambulatory arrhythmia monitoring devices market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.